-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Migraine sufferers process sensory information differently
In this study, it was decided to treat the (possibly activated) occipital cortex of patients with EM with stimulated anode TDC, adapting the stimulation pattern to the assumed cortical pre-activation level of the participant's visual cortex
Compared with sham stimulation, anode tDCS can lead to long-term reduction of migraine days in patients with EM
The position of the active electrode on the visual cortex
The position of the active electrode on the visual cortexThis study is single-blind and randomized
T1 is the 28-day stimulation period, and T2, T3, T4, and T5 are the next four 28-day follow-up periods; compared with the baseline check, the average change at T4 is significantly different (p=0.
Prophylactic treatment of anode tDCS on the occipital cortex can significantly reduce the number of migraine days after the 28-day stimulation period
In short, it is meaningful to explore whether prolonged stimulation can provide longer-lasting therapeutic benefits in future studies
Pohl, H.
Pohl, H.
Leave a message here